HWHongtao Wang

Hongtao Wang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Hongtao Wang has a total of 6 co-authors. Here are the top co-authors by number of shared publications:

  • Haibin Pan

    Department of Radiology, Shanghai University of Medicine & Health Sciences Affiliated Fengxian Hospital, 6600 Nanfeng Road, Shanghai 201499, China

    1 shared publication
  • Jun Lu

    Department of Endocrinology, Putuo Hospital, Shanghai University of Traditional Chinese Medicine

    1 shared publication
  • Lianzhou Wang

    Australian Institute for Bioengineering and Nanotechnology and School of Chemical Engineering, The University of Queensland, Brisbane, Australia

    1 shared publication
  • Meixiang Guo

    Shanghai Fengxian District Central Hospital, Shanghai, China

    1 shared publication
  • Xueli Zhang

    Department of General Surgery, Shanghai Fengxian Central Hospital, Affiliated to Southern Medical University, Shanghai, China

    1 shared publication
  • Xuemei Yu

    Diabetes Ward, Fengxian District Central Hospital Department of Endocrinology and Metabolism Shanghai 201406

    1 shared publication

Latest Publications

  • Open Access

    Association between Pancreatic Atrophy and Loss of Insulin Secretory Capacity in Patients with Type 2 Diabetes Mellitus

    by Jun Lu, Meixiang Guo, Hongtao Wang, Haibin Pan, Liang Wang, Xuemei Yu, Xueli Zhang

    Aims. To examine pancreatic volume (PV) changes among patients with different duration of type 2 diabetes and whether pancreatic atrophy was associated with loss of insulin secretory capacity. Methods. This cross-sectional study (203 patients with type 2 diabetes, 93 controls without diabetes) was conducted from January 2016 to December 2017. Patients with type 2 diabetes were divided into 3 groups: recently diagnosed (duration≤2 years), midterm (duration 3-9 years), and long term (duration≥10 years). All the patients were scanned with upper abdominal computerized tomography; PV was then calculated by an experienced technician. Absolute insulin deficiency was defined as fasting C−peptide<0.9 ng/mL. Results. Compared with PV (cm3) in the controls, the mean PV was similar in patients with recently diagnosed type 2 diabetes (68.8 versus 71.0, P=0.56) but significantly reduced in patients with midterm (68.8 versus 60.8, P<0.05) and long-term (68.8 versus 53.1, P<0.001) type 2 diabetes. A similar trend was observed for the PV index (PV adjusted for body surface area and body mass index). Furthermore, rates of pancreatic atrophy and absolute insulin deficiency increased with duration of diabetes. Multiple logistic regression analysis indicated that pancreatic atrophy was associated with higher likelihood of absolute insulin deficiency (odds ratio=4.47, 95%confidence interval=1.45‐13.8). Conclusions. PV was reduced in those with midterm and long-term type 2 diabetes compared to individuals without type 2 diabetes. Overall, pancreatic atrophy was associated with the loss of insulin secretory capacity in patients with type 2 diabetes.